tirzepatide head to head semaglutide SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Semaglutide vs Tirzepatide: Effectiveness, Side

doi:10.1038/nrendo.2015.3 13

This may be due to the complexation of copper to the small biologically active peptide, GHK 45

This means less degradation, less first-pass metabolism, and a far more direct route to the bloodstream

Table of Contents Retatrutide and Diarrhoea: What the Evidence Shows Phase 2 trial data confirm diarrhoea is a common adverse effect of retatrutide, driven largely by its GLP-1 receptor agonist component, which slows gastric emptying and alters intestinal transit

Semaglutide is one of the most studied and widely prescribed GLP-1 medications available

To date, GLP-1 Probiotic Pro has not been studied in women who are either pregnant, planning to become pregnant, or breastfeeding